Metallothionein: A multifunctional protein from toxicity to cancer

被引:88
作者
Theocharis, SE
Margeli, AP
Koutselinis, A
机构
[1] Univ Athens, Sch Med, Dept Forens Med & Toxicol, GR-10679 Athens, Greece
[2] Aghia Sophia Childrens Hosp, Dept Clin Biochem, Athens, Greece
关键词
metallothionein; cancer; apoptosis; cell proliferation; drug resistance; EXHIBITS REDUCED TOLERANCE; TUMOR-SUPPRESSOR PROTEIN; GROWTH-INHIBITORY FACTOR; METAL-IONS; NITRIC-OXIDE; DOWN-REGULATION; ULTRAVIOLET-B; ZINC TRANSFER; DNA-BINDING; IN-VITRO;
D O I
10.1177/172460080301800302
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The metallothionein (MT) family is a class of low molecular weight, intracellular and cysteine-rich proteins presenting high affinity for metal ions. Although the members of this family were discovered nearly 40 years ago, their functional significance remains obscure. Four major MT isoforms, MT-1, MT-2, MT-3 and MT-4, have been identified in mammals. MTs are involved in many pathophysiological processes such as metal ion homeostasis and detoxification, protection against oxidative damage, cell proliferation and apoptosis, chemoresistance and radiotherapy resistance. MT isoforms have been shown to be involved in several aspects of the carcinogenic process, cancer development and progression. MT expression has been implicated as a transient response to any form of stress or injury providing cytoprotective action. Although WIT participates in the carcinogenic process, its use as a potential marker of tumor differentiation or cell proliferation, or as a predictor of poor prognosis remains unclear. In the present review the involvement of NIT in defense mechanisms to toxicity and in carcinogenicity is discussed.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 65 条
[1]  
AbdelMageed AB, 1997, CANCER GENE THER, V4, P199
[2]  
Akiyama S, 1999, ANTI-CANCER DRUG DES, V14, P143
[3]   Metallothionein and apoptosis during differentiation of myoblasts to myotubes: Protection against free radical toxicity [J].
Apostolova, MD ;
Ivanova, IA ;
Cherian, MG .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 159 (03) :175-184
[4]   Metallothionein in radiation exposure: its induction and protective role [J].
Cai, L ;
Satoh, M ;
Tohyama, C ;
Cherian, MG .
TOXICOLOGY, 1999, 132 (2-3) :85-98
[5]  
CHERIAN MG, 1993, CANCER RES, V53, P922
[6]  
CHERIAN MG, 1994, TOXICOL APPL PHARM, V126, P1, DOI 10.1006/taap.1994.1083
[7]   CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[8]   DIVALENT METAL-IONS INDUCE CONFORMATIONAL CHANGE IN PURE, HUMAN WILD-TYPE P53 TUMOR-SUPPRESSOR PROTEIN [J].
COFFER, AI ;
KNOWLES, PP .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1994, 1209 (02) :279-285
[9]  
Fabisiak JP, 2002, METHOD ENZYMOL, V353, P268
[10]  
HAINAUT P, 1993, CANCER RES, V53, P1739